mechanism of action glp-1 agonist Possible mechanisms of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight GLP1-GIP receptor co-agonists: a promising
Description
Early trials have found benefits for both obesity [172] and diabetes [173], expanding oral GLP-1 RA choices
Materials and methods This article is based on the review of previously published data and does not involve any new studies on human or animal subjects performed by any of the authors
Future work is necessary to understand the mechanisms and signalling pathways downstream of GIPR in neurons
Tuttle KR, McGill JB, Haney DJ, Lin TE, Anderson PW
[PMC free article] [PubMed] [Google Scholar] 97
Most plant extracts and compounds associated with metabolic health do not meet these criteria
